Cart
sales@molnova.com
Brain Injury Derived Neurotrophic Peptide
CAS No. 148330-12-5
Brain Injury Derived Neurotrophic Peptide( ——— )
Catalog No. M42153 CAS No. 148330-12-5
Brain Injury Derived Neurotrophic Peptide
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBrain Injury Derived Neurotrophic Peptide
-
NoteResearch use only, not for human use.
-
Brief DescriptionBrain Injury Derived Neurotrophic Peptide
-
DescriptionBrain Injury Derived Neurotrophic Peptide
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number148330-12-5
-
Formula Weight1387.61
-
Molecular FormulaC62H102N18O18
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
11-Oxomogroside IVa
The fruits of Siraitia grosvenorii Swingle.
-
Quercetin 3-O-β-D-ga...
Quercetin 3-O-β-D-galactosyl-(1→2)-α-L-rhamnosyl-7-O-β-D-glucoside
-
(-)-Epiafzelechin
(-)-Epiafzelechin exhibits significant anti-inflammatory activity on carrageenin-induced mouse paw edema, it exhibits a dose-dependent inhibition on the COX activity with an IC50 value of 15 microM, it exhibits about 3-fold weaker inhibitory potency on the enzyme activity than indomethacin as a positive control.
